financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Keeps Strong Sell Opinion On Shares Of Cintas Corporation
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Keeps Strong Sell Opinion On Shares Of Cintas Corporation
May 1, 2024 6:29 AM

09:05 AM EDT, 05/01/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our 12-month target to $620 from $550, 38.4x our FY 25 (May) EPS outlook (adjusted to $16.15 from $16.37; we lift FY 24's estimate to $14.90 from $14.65), above the company's five-year forward P/E multiple average. A beat on earnings and raised guidance is driving today's positive movement in share price. CTAS posted Feb-Q EPS of $3.84 vs. $3.18 (+22% Y/Y), $0.26 above consensus. Feb-Q sales were roughly in line with expectations, up 10% Y/Y (an increase of 8% on an organic basis). Margin performance drove earnings expansion during the quarter, with operating income margin widening by 120 bps to 21.6%. Profitability benefited from volume growth, technology improvements, and gains from investment into operational efficiencies. Investment into route optimization and plant equipment utilization are bearing fruit. Despite the solid quarter and our positive view of CTAS's execution on margins and sales expansion, we view valuation as extended, with a forward P/E of 40x at nearly double that of the S&P 500.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novartis Ag
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novartis Ag
Apr 23, 2024
12:45 PM EDT, 04/23/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our target price by $3 to $108, implying a 2024 P/E of 15.4x, largely in line with the peer average. Novartis ( NVS ) raised its full-year 2024...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Invesco Ltd.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Invesco Ltd.
Apr 23, 2024
10:45 AM EDT, 04/23/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We trim our 12-month target by $2 to $16, valuing IVZ shares at 8.6x our 2025 adjusted EPS estimate of $1.85 (cut today by $0.05) and at 10x our 2024...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Msci Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Msci Inc.
Apr 23, 2024
11:40 AM EDT, 04/23/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We decrease our target price by $165 to $465, 27.4x our 2025 EPS estimate, a discount to MSCI's ( MSCI ) 10-year forward P/E average of 36.4x given reduced growth...
Research Alert: CFRA Reiterates Hold Opinion On Shares Of Jetblue Airways Corporation
Research Alert: CFRA Reiterates Hold Opinion On Shares Of Jetblue Airways Corporation
Apr 23, 2024
11:45 AM EDT, 04/23/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target of $6.50, down $0.50, reflects a 3.4x multiple of EV to projected '25 EBITDA, a discount to JBLU's historical average. We think a discount is merited due...
Copyright 2023-2026 - www.financetom.com All Rights Reserved